status: 200
content-location: http://rest.kegg.jp/get/path:map05012
server: Apache
date: Wed, 15 Oct 2014 14:58:54 GMT
content-type: text/plain

ENTRY       map05012                    Pathway
NAME        Parkinson's disease
DESCRIPTION Parkinson's disease (PD) is a progressive neurodegenerative movement disorder that results primarily from the death of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Mutations in alpha-synuclein, UCHL1 (a ubiquitin carboxy-terminal hydrolase L1), parkin, DJ1 (a parkin-associated protein involved with oxidative stress), and PINK1 (a putative serine threonine kinase) are known to cause early-onset PD. Mutations or altered expression of these proteins contributes to the damage and subsequent loss of DA neurons through common mechanisms that result in proteasome dysfunction, mitochondrial impairment, and oxidative stress. The demise of DA neurons located in the SNc leads to a drop in the dopaminergic input to the striatum. This results in a reduced activation of the direct pathway and in a disinhibition of the indirect pathway, which is associated with the elevation of adenosine A2A receptor transmission. Such unbalanced activity of the striatal output pathway is at the basis of the motor impairment observed in PD.
CLASS       Human Diseases; Neurodegenerative diseases
PATHWAY_MAP map05012  Parkinson's disease
DISEASE     H00057  Parkinson's disease (PD)
REFERENCE   PMID:17911161
  AUTHORS   Thomas B, Beal MF
  TITLE     Parkinson's disease.
  JOURNAL   Hum Mol Genet 16 Spec No. 2:R183-94 (2007)
REFERENCE   PMID:12938733
  AUTHORS   Lim KL, Lim TM
  TITLE     Molecular mechanisms of neurodegeneration in Parkinson's disease: clues from Mendelian syndromes.
  JOURNAL   IUBMB Life 55:315-22 (2003)
REFERENCE   PMID:16022590
  AUTHORS   Moore DJ, West AB, Dawson VL, Dawson TM
  TITLE     Molecular pathophysiology of Parkinson's disease.
  JOURNAL   Annu Rev Neurosci 28:57-87 (2005)
REFERENCE   PMID:16495942
  AUTHORS   Abou-Sleiman PM, Muqit MM, Wood NW
  TITLE     Expanding insights of mitochondrial dysfunction in Parkinson's disease.
  JOURNAL   Nat Rev Neurosci 7:207-19 (2006)
REFERENCE   PMID:18426756
  AUTHORS   Mizuno Y, Hattori N, Kubo S, Sato S, Nishioka K, Hatano T, Tomiyama H, Funayama M, Machida Y, Mochizuki H
  TITLE     Progress in the pathogenesis and genetics of Parkinson's disease.
  JOURNAL   Philos Trans R Soc Lond B Biol Sci 363:2215-27 (2008)
REFERENCE   PMID:16278972
  AUTHORS   Gandhi S, Wood NW
  TITLE     Molecular pathogenesis of Parkinson's disease.
  JOURNAL   Hum Mol Genet 14 Spec No. 2:2749-2755 (2005)
REFERENCE   PMID:12461550
  AUTHORS   Lotharius J, Brundin P
  TITLE     Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein.
  JOURNAL   Nat Rev Neurosci 3:932-42 (2002)
REFERENCE   PMID:15767499
  AUTHORS   Eriksen JL, Wszolek Z, Petrucelli L
  TITLE     Molecular pathogenesis of Parkinson disease.
  JOURNAL   Arch Neurol 62:353-7 (2005)
REFERENCE   PMID:15054086
  AUTHORS   Sidhu A, Wersinger C, Vernier P
  TITLE     Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
  JOURNAL   FASEB J 18:637-47 (2004)
REFERENCE   PMID:15681812
  AUTHORS   Sidhu A, Wersinger C, Moussa CE, Vernier P
  TITLE     The role of alpha-synuclein in both neuroprotection and neurodegeneration.
  JOURNAL   Ann N Y Acad Sci 1035:250-70 (2004)
REFERENCE   PMID:12971891
  AUTHORS   Dauer W, Przedborski S
  TITLE     Parkinson's disease: mechanisms and models.
  JOURNAL   Neuron 39:889-909 (2003)
REFERENCE   PMID:15525720
  AUTHORS   Feany MB
  TITLE     New genetic insights into Parkinson's disease.
  JOURNAL   N Engl J Med 351:1937-40 (2004)
REFERENCE   PMID:11331916
  AUTHORS   Beal MF
  TITLE     Experimental models of Parkinson's disease.
  JOURNAL   Nat Rev Neurosci 2:325-34 (2001)
REFERENCE   PMID:15770999
  AUTHORS   Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A
  TITLE     Parkinson's disease: from causes to mechanisms.
  JOURNAL   C R Biol 328:131-42 (2005)
REFERENCE   PMID:18680555
  AUTHORS   Vila M, Ramonet D, Perier C
  TITLE     Mitochondrial alterations in Parkinson's disease: new clues.
  JOURNAL   J Neurochem 107:317-28 (2008)
REFERENCE   PMID:12728264
  AUTHORS   Vila M, Przedborski S
  TITLE     Targeting programmed cell death in neurodegenerative diseases.
  JOURNAL   Nat Rev Neurosci 4:365-75 (2003)
REFERENCE   PMID:22927178
  AUTHORS   Calabresi P, Di Filippo M, Gallina A, Wang Y, Stankowski JN, Picconi B, Dawson VL, Dawson TM
  TITLE     New synaptic and molecular targets for neuroprotection in Parkinson's disease.
  JOURNAL   Mov Disord 28:51-60 (2013)
REFERENCE   PMID:21811441
  AUTHORS   Nishi A, Kuroiwa M, Shuto T
  TITLE     Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons.
  JOURNAL   Front Neuroanat 5:43 (2011)
REFERENCE   PMID:20236221
  AUTHORS   Hara M, Fukui R, Hieda E, Kuroiwa M, Bateup HS, Kano T, Greengard P, Nishi A
  TITLE     Role of adrenoceptors in the regulation of dopamine/DARPP-32 signaling in neostriatal neurons.
  JOURNAL   J Neurochem 113:1046-59 (2010)
KO_PATHWAY  ko05012
///
